Literature DB >> 24339051

Racial variation in the quality of surgical care for bladder cancer.

Daniel A Barocas1, Joann Alvarez, Tatsuki Koyama, Christopher B Anderson, Darryl T Gray, Jay H Fowke, Chaochen You, Sam S Chang, Michael S Cookson, Joseph A Smith, David F Penson.   

Abstract

BACKGROUND: Differences in quality of care may contribute to racial variation in outcomes of bladder cancer (BCa). Quality indicators in patients undergoing surgery for BCa include the use of high-volume surgeons and high-volume hospitals, and, when clinically indicated, receipt of pelvic lymphadenectomy, receipt of continent urinary diversion, and undergoing radical cystectomy instead of partial cystectomy. The authors compared these quality indicators as well as adverse perioperative outcomes in black patients and white patients with BCa.
METHODS: The Healthcare Cost and Utilization Project State Inpatient Databases for New York, Florida, and Maryland (1996-2009) were used, because they consistently included race, surgeon, and hospital identifiers. Quality indicators were compared across racial groups using regression models adjusting for age, sex, Elixhauser comorbidity sum, insurance, state, and year of surgery, accounting for clustering within hospital.
RESULTS: Black patients were treated more often by lower volume surgeons and hospitals, they had significantly lower receipt of pelvic lymphadenectomy and continent diversion, and they experienced higher rates of adverse outcomes compared with white patients. These associations remained significant for black patients who received treatment from surgeons and at hospitals in the top volume decile.
CONCLUSIONS: Black patients with BCa had lower use of experienced providers and institutions for BCa surgery. In addition, the quality of care for black patients was lower than that for whites even if they received treatment in a high-volume setting. This gap in quality of care requires further investigation.
© 2013 American Cancer Society.

Entities:  

Keywords:  bladder cancer; health disparities; quality of care; surgery

Mesh:

Year:  2013        PMID: 24339051      PMCID: PMC3961490          DOI: 10.1002/cncr.28520

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  27 in total

1.  Impact of hospital and surgeon volume on in-hospital mortality from radical cystectomy: data from the health care utilization project.

Authors:  Badrinath R Konety; Vibhu Dhawan; Veerasathpurush Allareddy; Sue A Joslyn
Journal:  J Urol       Date:  2005-05       Impact factor: 7.450

2.  Factors affecting outcomes after radical cystectomy in African Americans.

Authors:  Badrinath R Konety; Veerasathpurush Allareddy; Peter R Carroll
Journal:  Cancer       Date:  2007-02-01       Impact factor: 6.860

3.  Surgical benchmarks for the treatment of invasive bladder cancer.

Authors:  Eila C Skinner; John P Stein; Donald G Skinner
Journal:  Urol Oncol       Date:  2007 Jan-Feb       Impact factor: 3.498

4.  Racial disparity in bladder cancer: trends in tumor presentation at diagnosis.

Authors:  Cheryl T Lee; Rodney L Dunn; Candice Williams; Willie Underwood
Journal:  J Urol       Date:  2006-09       Impact factor: 7.450

5.  Complications after radical cystectomy: analysis of population-based data.

Authors:  Badrinath R Konety; Veerasathpurush Allareddy; Harry Herr
Journal:  Urology       Date:  2006-06-27       Impact factor: 2.649

6.  Quality of care: partial cystectomy for bladder cancer--a case of inappropriate use?

Authors:  Brent K Hollenbeck; David A Taub; Rodney L Dunn; John T Wei
Journal:  J Urol       Date:  2005-09       Impact factor: 7.450

7.  Variations in reconstruction after radical cystectomy.

Authors:  John L Gore; Christopher S Saigal; Jan M Hanley; Matthias Schonlau; Mark S Litwin
Journal:  Cancer       Date:  2006-08-15       Impact factor: 6.860

8.  Sex and racial differences in bladder cancer presentation and mortality in the US.

Authors:  Emil Scosyrev; Katia Noyes; Changyong Feng; Edward Messing
Journal:  Cancer       Date:  2009-01-01       Impact factor: 6.860

9.  Association of insurance status and ethnicity with cancer stage at diagnosis for 12 cancer sites: a retrospective analysis.

Authors:  Michael T Halpern; Elizabeth M Ward; Alexandre L Pavluck; Nicole M Schrag; John Bian; Amy Y Chen
Journal:  Lancet Oncol       Date:  2008-02-20       Impact factor: 41.316

Review 10.  Candidate quality of care indicators for localized bladder cancer.

Authors:  Matthew R Cooperberg; Michael P Porter; Badrinath R Konety
Journal:  Urol Oncol       Date:  2009 Jul-Aug       Impact factor: 3.498

View more
  13 in total

1.  Racial and Socioeconomic Disparities in Bladder Cancer Survival: Analysis of the California Cancer Registry.

Authors:  John M Sung; Jeremy W Martin; Francis A Jefferson; Daniel A Sidhom; Keyhan Piranviseh; Melissa Huang; Nobel Nguyen; Jenny Chang; Argyrios Ziogas; Hoda Anton-Culver; Ramy F Youssef
Journal:  Clin Genitourin Cancer       Date:  2019-05-31       Impact factor: 2.872

2.  Overall and recurrence-free survival among black and white bladder cancer patients in an equal-access health system.

Authors:  Jill K Schinkel; Stephanie Shao; Shelia H Zahm; Katherine A McGlynn; Craig D Shriver; Kangmin Zhu
Journal:  Cancer Epidemiol       Date:  2016-05-06       Impact factor: 2.984

3.  Cancer and All-cause Mortality in Bladder Cancer Patients Undergoing Radical Cystectomy: Development and Validation of a Nomogram for Treatment Decision-making.

Authors:  Stephen B Williams; Jinhai Huo; Yiyi Chu; Jacques G Baillargeon; Timothy Daskivich; Yong-Fang Kuo; Christopher D Kosarek; Simon P Kim; Eduardo Orihuela; Douglas S Tyler; Stephen J Freedland; Ashish M Kamat
Journal:  Urology       Date:  2017-08-25       Impact factor: 2.649

Review 4.  Bladder Cancer Survivorship.

Authors:  Sumeet K Bhanvadia
Journal:  Curr Urol Rep       Date:  2018-11-09       Impact factor: 3.092

5.  Population-based assessment of racial/ethnic differences in utilization of radical cystectomy for patients diagnosed with bladder cancer.

Authors:  Stephen B Williams; Jinhai Huo; Christopher D Kosarek; Karim Chamie; Selwyn O Rogers; Michele A Williams; Sharon H Giordano; Simon P Kim; Ashish M Kamat
Journal:  Cancer Causes Control       Date:  2017-05-05       Impact factor: 2.506

6.  Gender, race, and variation in the evaluation of microscopic hematuria among Medicare beneficiaries.

Authors:  Jeffrey C Bassett; JoAnn Alvarez; Tatsuki Koyama; Matthew Resnick; Chaochen You; Shenghua Ni; David F Penson; Daniel A Barocas
Journal:  J Gen Intern Med       Date:  2014-12-02       Impact factor: 5.128

7.  Variation in the Diagnostic Evaluation among Persons with Hematuria: Influence of Gender, Race and Risk Factors for Bladder Cancer.

Authors:  Jacob T Ark; JoAnn R Alvarez; Tatsuki Koyama; Jeffrey C Bassett; William J Blot; Michael T Mumma; Matthew J Resnick; Chaochen You; David F Penson; Daniel A Barocas
Journal:  J Urol       Date:  2017-06-24       Impact factor: 7.450

8.  Colon cancer lymph node evaluation among military health system beneficiaries: an analysis by race/ethnicity.

Authors:  Abegail A Gill; Shelia H Zahm; Craig D Shriver; Alexander Stojadinovic; Katherine A McGlynn; Kangmin Zhu
Journal:  Ann Surg Oncol       Date:  2014-07-25       Impact factor: 5.344

9.  Race and 30-Day Morbidity in Pediatric Urologic Surgery.

Authors:  David I Chu; Douglas A Canning; Gregory E Tasian
Journal:  Pediatrics       Date:  2016-06-17       Impact factor: 7.124

10.  Social Determinants of Appropriate Treatment for Muscle-Invasive Bladder Cancer.

Authors:  Samuel L Washington; John Neuhaus; Maxwell V Meng; Sima P Porten
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-05-15       Impact factor: 4.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.